Jaideep Dudani
Private Equity Investor bei Monograph Capital Advisors (UK) LLP
Aktive Positionen von Jaideep Dudani
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Private Equity Investor | 01.07.2021 | - |
Karriereverlauf von Jaideep Dudani
Ehemalige bekannte Positionen von Jaideep Dudani
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RELAY THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2019 | 30.06.2021 |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Berater | 01.01.2018 | 31.03.2018 |
Ausbildung von Jaideep Dudani
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Private Equity Investor | 1 |
| Corporate Officer/Principal | 1 |
| Consultant / Advisor | 1 |
Sektoral
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RELAY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Finance |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jaideep Dudani
- Erfahrung
